2m 2m 2m 2m 2m 2m 2m
ADVANCED BIOMED (ADVB)
NASDAQ
$6.67+$1.57 (+30.86%)
Price as of Jul 14, 2026 6:36 AM EDT- $8.4MMarket Cap
- -68.12%1-Year Change
- Diagnostics & ResearchIndustry
ADVANCED BIOMED (ADVB)
$6.67+$1.57 (+30.86%)
ADVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.10 | ||
Change | -$0.06 (-1.16%) | ||
Open | $5.10 | ||
High | $5.51 | ||
Low | $5.05 | ||
Previous Close | $5.16 | ||
Volume | 32,433 | ||
30-Day Average Volume | 21,995 | ||
1-Week Change | 0.49% | ||
1-Month Change | 13.33% | ||
1-Year Change | -68.12% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $10.6M | ||
Market Cap | $8.4M | ||
Enterprise Value | $6.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$488,942.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$488,830.00 | ||
EBITDA | -$479,504.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/20/2026 | ||